OR | 95% CI | P value | |
Age | 1.05 | 1.02 to 1.09 | 0.005 |
Weight | 0.97 | 0.95 to 1.0 | 0.081 |
NT-proBNP | 1.00 | 1.0 to 1.0 | 0.103 |
Haemoglobin | 0.98 | 0.95 to 1.0 | 0.068 |
Albumin | 0.93 | 0.85 to 1.01 | 0.1 |
eGFR | 0.98 | 0.97 to 1.0 | 0.061 |
Heart failure (Killip class) | 1.66 | 0.97 to 2.84 | 0.066 |
Systolic blood pressure | 1.02 | 1 to 1.03 | 0.03 |
Predilation balloon inflation pressure | 1.17 | 1 to 1.62 | 0.05 |
Aspirin to balloon time | 1.00 | 1 to 1.01 | 0.13 |
P2Y12 antagonist to balloon time | 1.01 | 1 to 1.01 | 0.036 |
Smoker | 0.38 | 0.13 to 1.08 | 0.07 |
Hypertension | 2.39 | 1 to 5.72 | 0.051 |
Intracoronary IIb/IIIa use | 6.59 | 0.88 to 49.22 | 0.066 |
Intravenous fluid use | 2.12 | 0.88 to 5.1 | 0.095 |
Presence of multivessel disease | 1.73 | 0.64 to 4.63 | 0.28 |
Classification | |||
B2 versus B1 | 8.47 | 1.09 to 66.13 | 0.042 |
C versus B1 | 24.0 | 2.78 to 206.96 | 0.004 |
B2 versus C | 0.35 | 0.13 to 0.97 | 0.043 |
Figures show OR, 95% CI and subsequent p value. Killip class was entered as continuous variable. P<0.05 was deemed significant; however, a p <0.1 (bold) was considered for the prediction model.
eGFR, estimated glomerular filtration rate; NT-proBNP, N-terminal pro-B-type natriuretic peptide.